Ubivac
Get Full AccessDescription
- UbiVac is a clinical stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer. UbiVacs leading platform technology, Autophagosome-enriched DRibble vaccine (DRibbles), having been used in a National Cancer Institute (NCI) funded Phase I clinical trial for non-small cell lung cancer has begun an NCI funded, multi-center Phase II clinical trial for this disease.
-
Headquarters:18183 Sw Boones Ferry Rd , Portland, Oregon, United States
More -
Phone Number: +1 503-431-2228
-
Website: https://www.ubivac.com
-
Employees:7
-
Revenue:$1 - 10M
-
Legal Name:Ubivac
-
Ubivac's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Ubivac
-
Where are Ubivac's Headquarters?
Ubivac's Headquarters are in 18183 Sw Boones Ferry Rd ,Portland,Oregon,United States
-
What is Ubivac's phone number?
Ubivac's phone number is +1 503-431-2228
-
What is Ubivac's official website?
Ubivac's official website is https://www.ubivac.com
-
What is Ubivac's Revenue?
Ubivac's revenue is $1 - 10M
-
What is Ubivac's NAICS code?
Ubivac's NAICS code is 541713
-
How many employees are working in Ubivac
Ubivac has 7 employees
-
What is Ubivac's Industry?
Ubivac is in the industry of Biotechnology
-
Who is Ubivac's CEO?
Ubivac's CEO is Bernard Fox